Drugs and Devices

FDA approves new MS drug

On Sept. 12, the U.S. Food and Drug Administration (FDA) approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS). Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares